About United BioSource Corporation
United BioSource Corporation is a Healthcare company based in Blue Bell (United States) founded in 2003, and was acquired by Avista Capital Partners in November 2017. Pharmaceutical support services. United BioSource Corporation has raised $278 million across 3 funding rounds from investors including J P Morgan, PNC and Express Scripts. United BioSource Corporation has completed 5 acquisitions, including BioCor, Cognitive Drug Research and Examoto. Its website ubc.com draws about 279 thousand monthly visits. United BioSource Corporation offers products and services including Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Late Stage. Its legal entity is UBC LATE STAGE (UK) LIMITED. Its competitors include Launch Therapeutics, Concentrics Research and Nexus Biosciences.
Company details
United BioSource Corporation provides pharmaceutical support services. Services include clinical development and late stage clinical research, trial management, risk monitoring, risk evaluation and mitigation strategies, risk management plans, reimbursement patient assistance, along with support programs designed to enhance patients adherence. It also offers CLÆRITY and SÆfetyworks web based analytical softwares and has partnered with Accredo Specialty Pharmacy and CuraScript Specialty Distribution to help pharmaceutical and biotech manufacturers maximize product access and commercialization.
- Headquarters Blue Bell, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website ubc.com
- Social LinkedIn X
- Acquired by Avista Capital Partners (Nov 2017)
- Legal Name Ubc Late Stage (Uk) Limited
- Total Equity Funding$278M (USD)
in 3 rounds
- Latest Funding Round$150M (USD), Debt – Conventional
Jul 2010
- InvestorsJ P Morgan
& 9 more
- Investments & AcquisitionsBioCor
& 4 more
- Acquired by
Products & Services of United BioSource Corporation
United BioSource Corporation offers a comprehensive portfolio of products and services, including Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions.
Solutions for generating real-world evidence and analytics.
Services to manage product safety and compliance.
Programs for improving therapy affordability and adherence.
Tools to accelerate innovation and data insights.
Funding Insights of United BioSource Corporation
United BioSource Corporation has successfully raised a total of $278M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $150 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $278M
- Total Rounds 3
- Last Round Debt – Conventional — $150M
- First Round $153M
(Dec 2003)
- Investors Count 8
All 3 funding rounds of United BioSource Corporation with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2010 | $150M | Debt – Conventional | – | – | |
| Oct 2009 | $125M | Private Equity Round | – | – | |
| Dec 2003 | $153M | Private Equity Round | – | – |
10 investors in total: 10 institutional.
Investors in United BioSource Corporation
United BioSource Corporation has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include J P Morgan, PNC and Express Scripts.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward growth-stage companies. | berkshirepartners.com | Boston, United States | ||
Early-stage US tech startups are invested in by Grotech Ventures. | grotech.com | Arlington, United States | ||
| whitney.com | ||||
Venture capital investments are made in disruptive growth companies. | oakvc.com | Greenwich, United States | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Diverse financial services and online banking are provided to clients. | 1852 | wellsfargo.com | San Francisco, United States | |
Comprehensive financial services are provided to corporations and individuals. | 1799 | jpmorgan.com | New York, United States | |
Commercial banking and financing services are provided by PNC. | 1845 | pnc.com | Pittsburgh, United States | |
Private equity investments are focused on the United States market. | avistacap.com | New York, United States | ||
Pharmacy benefit management services are delivered through SaaS platforms. | 1986 | express-scripts.com | St. Louis, United States |
Investor details for United BioSource Corporation
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of United BioSource Corporation
246 people are tracked at United BioSource Corporation (76 in leadership, 170 in team).
| Name | Role | Group |
|---|---|---|
Patrick Lindsay | Executive Vice President | Leadership |
Ronald Lacy | Vp, Products & Innovation | Leadership |
Laurent Vidal | Associate Director, Pharmacovigilance | Leadership |
Milena T. | Project Director | Leadership |
Marci Gott Bsn | Executive Director Patient Services | Leadership |
Patty Frank | Vice President, Pricing Strategy | Leadership |
Aaron Berger | Head of Evidence Development Solutions | Leadership |
Judy Lytle | Executive Director, Evidence Development (medical Affairs & Rwe) | Leadership |
Jeff Lowry | Senior Director Of Software Engineering | Leadership |
Eileen Moran | Executive Director, Evidence Development Operations | Leadership |
Ida Pranger | Executive Director Human Resources | Leadership |
Anna Kowalczyk | Senior Director Project Managent | Leadership |
Geraldine Aubes | Executive Director, Global Head Of Pharmacovigilance | Leadership |
Christopher Foley | Director Of Business Development | Leadership |
Miriana Wennekes | Director Clinical Research Including Line Management | Leadership |
Anne Santovito | Executive Director, REMS Business Strategy And Operations | Leadership |
Inci Porter | Senior Director, Account Management | Leadership |
Danilo A. Belloso | Director Of Business Development | Leadership |
Susan Thompson | Director | Leadership |
Glynis Daniel-Archibald M.D./Mba/Pmp | Executive Director | Leadership |
226 more people are available in the full profile.
Complete people profiles for United BioSource Corporation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by United BioSource Corporation
United BioSource Corporation has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include BioCor, Cognitive Drug Research and Examoto.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
IT services are provided to the healthcare sector. | examoto.com | Bryn Mawr, United States | 2012 | Jul 2022 | •••• | |
Software solutions for pharmacovigilance reporting and analysis are provided. | prosanos.com | Harrisburg, United States | 2000 | Nov 2010 | •••• | |
Automated cognitive function assessment for clinical trials is provided. | cognitivedrugresearch.com | Goring, United Kingdom | 1986 | Sep 2009 | •••• | |
Multi-speciality healthcare services are delivered by Biocor hospital in Brazil. | biocor.com.br | Nova Lima, Brazil | 1985 | Nov 2006 | •••• | |
Pharmacy benefits are managed for healthcare clients by Pharmastar. | pharmastarpbm.com | Eau Claire, United States | 1997 | Apr 2005 | •••• |
Complete acquisition details for United BioSource Corporation
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of United BioSource Corporation
10 dated milestones of United BioSource Corporation across 19 years, from founding to its latest funding, stage changes and deals.
- Founded United BioSource Corporation is founded.
- Funding First funding round of $153.0M.
- Acquisition Acquires Pharmastar.
- Acquisition Acquires BioCor.
- Acquisition Acquires Cognitive Drug Research.
- Funding Latest funding round, Debt – Conventional, of $150.0M.
- Exit Acquired by Express Scripts.
- Acquisition Acquires ProSanos.
- Exit Acquired by Avista Capital Partners.
- Acquisition Acquires Examoto.
Competitors of United BioSource Corporation
United BioSource Corporation has 3 listed competitors in our database. They include Launch Therapeutics, Concentrics Research and Nexus Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| launchtx.com | 2022 | Boston, United States | Late-stage clinical development services are provided for biopharma companies. | |||
| concentricsresearch.com | 1999 | Indianapolis, United States | 47 | Late-stage (Phase II-IV trials) CRO | ||
| nexusbiosciences.com | 2012 | Carlsbad, United States | CRO specializing in late stage, observational and post-approval studies |
Detailed competitors of United BioSource Corporation
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of United BioSource Corporation
The website of United BioSource Corporation (ubc.com) receives about 279.3K visits a month and ranks #178,109 among all websites worldwide, #5,672 in Biotechnology and Pharmaceuticals.
- Monthly visits279.3K
▲ 5% vs previous month
- Unique visitors127.6K
per month
- Global rank#178,109
among all websites
- Category rank#5,672
Health · Biotechnology and Pharmaceuticals
- Bounce rate63%
- Pages per visit2.0
- Average visit37 sec
- DevicesDesktop 69% · Mobile 31%
Websites whose visitors overlap most with United BioSource Corporation. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ipledgeprogram.com | 100% | #93,084 | View details | ||
| bracketglobal.com | 83% | 1.1K | #14,907,063 | View details | |
| syneoshealth.com | 70% | 199.6K | #198,509 | View details | |
| iqvia.com | 70% | 1.2M | #45,953 | View details | |
| visualdx.com | 53% | 286.6K | #137,622 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for United BioSource Corporation
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as United BioSource Corporation (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about United Biosource Corporation
Complete news archive for United BioSource Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about United BioSource Corporation
United BioSource Corporation was founded in 2003.
United BioSource Corporation is headquartered in Blue Bell, United States. It is registered at Blue Bell, Pennsylvania, United States.
United BioSource Corporation is a funded company, having raised a total of $278M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $153M, raised on Dec 2003.
United BioSource Corporation provides pharmaceutical support services. Services include clinical development and late stage clinical research, trial management, risk monitoring, risk evaluation and mitigation strategies, risk management plans, reimbursement patient assistance, along with support programs designed to enhance patients adherence. It also offers CLÆRITY and SÆfetyworks web based analytical softwares and has partnered with Accredo Specialty Pharmacy and CuraScript Specialty Distribution to help pharmaceutical and biotech manufacturers maximize product access and commercialization.
United BioSource Corporation's top competitors include Concentrics Research, Nexus Biosciences and Launch Therapeutics.
United BioSource Corporation offers Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions.
United BioSource Corporation has made 5 acquisitions, including BioCor, Cognitive Drug Research, and Examoto.
United BioSource Corporation has 10 investors. Key investors include J P Morgan, PNC, Express Scripts, Wells Fargo, and Berkshire Partners.
United BioSource Corporation operates through Ubc Late Stage (Uk) Limited.
Yes. United BioSource Corporation was acquired by Avista Capital Partners in November 2017.
The website of United BioSource Corporation receives about 279 thousand visits a month and ranks #178,109 among all websites worldwide.

